Rationale and design of a randomized phase 2 trial of gefitinib plus bevacizumab vs gefitinib alone in patients with epidermal growth factor receptor mutant non-squamous non-small-cell lung cancer: Study protocol
Chiyoe Kitagawa, Akiko Kada, Akiko M. Saito, Yukito Ichinose, Hideo Saka
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
2
被引用数
(Scopus)